share_log

益佰制药(600594.SH)发布前三季度业绩,净亏损1.69亿元

Guizhou Yibai Pharmaceutical (600594.SH) released its performance for the first three quarters, with a net loss of 0.169 billion yuan.

Zhitong Finance ·  Oct 25, 2024 19:06

Guizhou Yibai Pharmaceutical (600594.SH) released the third quarter report for 2024, with the company's revenue in the first three quarters of the year at 17...

According to the Zhitong Finance APP, Guizhou Yibai Pharmaceutical (600594.SH) released the third quarter report for 2024, with the company's revenue in the first three quarters of the year at 1.714 billion yuan, a year-on-year decrease of 19.80%; net loss attributable to the shareholders of the listed company was 0.169 billion yuan; net loss attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 0.18 billion yuan; basic loss per share was 0.214 yuan/share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment